Profile data is unavailable for this security.
About the company
Radiopharm Theranostics Limited is an Australia-based clinical-stage company developing a platform of radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. It has a pipeline of differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer, in pre-clinical and clinical stages of development from some of the universities and institutes around the world. The clinical program includes one Phase II and two Phase I trials in a variety of solid tumor cancers including lung, pancreas and brain. Its technologies include Nano-mAbs, Pivalate, AVB6 Integrin, PSA-mAb, DUNP19 and PTPu. Nano-mAbs is a radiopharmaceutical platform made using genetic engineered camelid derived single domain antibodies (sdAb) labelled with a radioisotope of therapeutic radiation. Pivalate is an 18F-FPIA radiotracer, based on a short chain carbohydrate that utilizes the early steps of fatty acid oxidation.
- Revenue in AUD (TTM)0.00
- Net income in AUD-46.82m
- Incorporated2021
- Employees--
- LocationRadiopharm Theranostics LtdLevel 3, 62 Lygon Street, CarltonMELBOURNE 3053AustraliaAUS
- Phone+61 39824-5254
- Websitehttps://radiopharmtheranostics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acrux Ltd | 14.46m | -709.00k | 19.19m | 43.00 | -- | 3.39 | -- | 1.33 | -0.0024 | -0.0024 | 0.0502 | 0.0195 | 1.29 | -- | 4.86 | -- | -6.34 | -39.91 | -9.21 | -46.00 | 72.38 | -- | -4.90 | -132.53 | -- | -- | 0.2861 | -- | 133.74 | 28.29 | 92.23 | -- | -16.66 | -- |
Immuron Ltd | 3.58m | -3.88m | 23.94m | 6.00 | -- | 1.36 | -- | 6.69 | -0.017 | -0.017 | 0.0157 | 0.0769 | 0.1664 | 0.6468 | 7.92 | 596,106.70 | -18.06 | -27.48 | -19.86 | -29.58 | 80.87 | 77.52 | -108.52 | -296.64 | 7.79 | -2.85 | 0.0023 | -- | 135.85 | -13.34 | -32.66 | -- | 3.27 | -- |
Little Green Pharma Ltd | 25.63m | -8.15m | 29.87m | -- | -- | 0.3846 | -- | 1.17 | -0.0272 | -0.0272 | 0.0856 | 0.2574 | 0.2772 | 1.05 | 12.29 | -- | -8.82 | -- | -9.74 | -- | 53.18 | -- | -31.81 | -- | 1.39 | -18.90 | 0.0624 | -- | 29.07 | -- | 4.72 | -- | -- | -- |
Oncosil Medical Ltd | 355.30k | -11.71m | 30.58m | 2.00 | -- | 4.61 | -- | 86.08 | -0.0081 | -0.0081 | 0.0002 | 0.002 | 0.0506 | -- | 7.88 | -- | -166.55 | -57.65 | -234.81 | -64.83 | -426.96 | -- | -3,295.08 | -473.02 | -- | -68.93 | 0.0256 | -- | -59.92 | -37.72 | -5.74 | -- | 40.13 | -- |
Radiopharm Theranostics Ltd | 0.00 | -46.82m | 37.01m | -- | -- | 0.5367 | -- | -- | -0.1343 | -0.1343 | 0.00 | 0.0652 | 0.00 | -- | -- | -- | -63.11 | -- | -77.85 | -- | -- | -- | -- | -- | -- | -7.48 | 0.00 | -- | -- | -- | -13.78 | -- | -- | -- |
Starpharma Holdings Ltd | 10.63m | -8.40m | 39.59m | 50.00 | -- | 1.15 | -- | 3.73 | -0.0205 | -0.0205 | 0.0259 | 0.0837 | 0.2092 | 0.282 | 2.10 | -- | -16.53 | -28.47 | -20.70 | -33.66 | 92.67 | 71.62 | -79.00 | -391.82 | 5.22 | -- | 0.0833 | -- | -14.10 | -3.22 | 3.19 | -- | 11.58 | -- |
Medical Developments International Ltd | 33.49m | -19.21m | 41.86m | 68.00 | -- | 0.553 | -- | 1.25 | -0.2226 | -0.2226 | 0.3882 | 0.877 | 0.3348 | 1.01 | 6.18 | -- | -19.20 | -6.67 | -22.18 | -7.43 | 69.64 | 69.90 | -57.36 | -23.55 | 1.93 | -- | 0.0311 | -- | 47.37 | 13.12 | 54.79 | -- | -6.41 | -- |
Syntara Ltd | 9.83m | -14.26m | 47.76m | 107.00 | -- | 5.30 | -- | 4.86 | -0.0197 | -0.0172 | 0.0136 | 0.0075 | 0.442 | 1.58 | 2.22 | -- | -64.13 | -27.33 | -97.76 | -34.23 | 81.69 | 88.37 | -145.11 | -61.99 | 1.75 | -262.59 | 0.0674 | -- | 23.60 | -18.30 | -486.78 | -- | -31.06 | -- |
Vitura Health Ltd | 119.67m | 9.40m | 53.56m | 121.00 | 5.65 | 1.36 | 14.16 | 0.4475 | 0.0165 | 0.0165 | 0.2099 | 0.0681 | 1.98 | 11.22 | 10.51 | 989,034.20 | 15.25 | 15.29 | 22.30 | 21.06 | 31.23 | -- | 7.70 | 6.92 | 1.18 | 5,598.19 | 0.2359 | -- | 75.16 | -- | 128.31 | 146.95 | 54.86 | -- |
Holder | Shares | % Held |
---|---|---|
Investors Mutual Ltd.as of 28 Jun 2024 | 17.81m | 3.87% |